A Review of Exceptions in State Abortion Bans: Implications for the Provision of Abortion Services June 6, 2024 Issue Brief This issue brief examines the varying exceptions (for life, health, rape/incest, and fatal fetal anomalies) in state abortion bans and restrictions and the complications that arise when pregnant people attempt to access abortion care under these exceptions.
Looking to the Future: Implications of the SCOTUS Ruling on Mifepristone June 13, 2024 Blog This issue brief details some of the implications of the Supreme Court’s June 13, 2024, ruling in the case Alliance for Hippocratic Medicine v. FDA.
Democratic Women are More Motivated to Vote in States with Potential Abortion Ballot Initiatives than in Other States June 20, 2024 News Release A new KFF poll of women voters reveals that the issue of abortion is boosting Democratic women’s eagerness to vote most in states with potential abortion-related ballot initiatives. As of mid-June, there are 10 states where voters may be deciding on abortion access in November, including 4 states where abortion…
10 Things to Know About Abortion Access Since the Dobbs Decision June 20, 2024 Blog This policy watch presents 10 key facts to know about abortion access two years after the Dobbs decision.
Q & A: Implications of Two Conflicting Federal Court Rulings on the Availability of Medication Abortion and the FDA’s Authority to Regulate Drugs April 8, 2023 Blog This policy watch explains the two conflicting rulings on the provision of mifepristone issued by two separate District Courts on April 7, 2023, Alliance for Hippocratic Medicine v. FDA and State of Washington v. United States Food and Drug Administration.
Update on the Status of Medication Abortion and the Courts April 21, 2023 Blog This policy watch explains the April 21, 2023 United States Supreme Court’s ruling on Alliance for Hippocratic Medicine v. FDA, a case challening the FDA’s approval of mifepristone, the medication abortion pill.
Emergency Abortion Care to Preserve the Health of Pregnant People: SCOTUS, EMTALA, and Beyond June 27, 2024 Blog This policy watch outlines SCOTUS’ June 27, 2024, decision dismissing the case, Moyle v. United States, where the Court had been asked to determine if a federal law called the Emergency Medical Treatment and Labor Act preempted Idaho’s abortion ban. The decision returns the case to the lower courts and reinstates a court order blocking enforcement of the Idaho ban where it prohibits abortion care for pregnant people having medical emergencies.
Abortion at SCOTUS: Dobbs v. Jackson Women’s Health May 4, 2022 Issue Brief This issue brief provides background on the legal challenges to the Mississippi law in the context of the Supreme Court abortion precedents, addresses the intersections with the litigation that has arisen from S.B. 8, the Texas 6-week abortion ban, and explains the potential outcomes and how they could impact access to abortion around the country.
What’s at Stake for Access to Medication Abortion and the FDA in the Supreme Court Case FDA v. the Alliance for Hippocratic Medicine? March 21, 2024 Issue Brief The Supreme Court will be hearing oral arguments for the case FDA v. Alliance for Hippocratic Medicine. This brief explains the issues at stake before the court and their implications for the drug regulatory process and medication abortion access throughout the country.
